Double maintains 2 strategies that include OCUL - Ocular Therapeutix, Inc.
Finnhub
BEDFORD - Ocular Therapeutix, Inc. , a biopharmaceutical company committed to redefining the retina experience, today announced that the Company will participate in two investor conferences in April:...
Yahoo
BEDFORD, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that the Company will participate in two investor conferences in April: 24th Annual Needham Virtual Healthcare ConferencePresentation Date: Monday, April 7, 2025Presentation Time: 3:00 PM ETPresenter: Pravin U. Dugel, MD, Executive Chairman, President and CEOLocation: Virtual Piper Sandler Spring Biopharma
Yahoo
The market was seeing Ocular Therapeutix (NASDAQ: OCUL) very positively this week, and that sunny view pushed the company's stock higher. As of Friday morning before market open, the eye care specialist's shares were up by nearly 5% in price week to date, according to data compiled by S&P Global Market Intelligence. Early Tuesday morning, Needham's Serge Belanger formally became an Ocular analyst.
Yahoo
Needham initiated coverage on Ocular Therapeutix Inc (NASDAQ:OCUL), noting the company’s lead asset, Axpaxli, an investigational axitinib-based intravitreal implant for wet age-related macular degeneration (wet AMD). Axpaxli is the company’s key value driver and is under evaluation in two phase 3 trials. If positive, these trials could support approval with a product label that enables maintenance treatment with Q6M (every 6 months)-Q12M (every 12 months) dosing, which would represent a signific
Finnhub
BEDFORD - Ocular Therapeutix, Inc. , a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to one newly hired employee.The...
Yahoo
BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to one newly hired employee. The awards were made as inducements material to the individual’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement equity awards were g
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBMS | 0.02% | $46.94M | 0.18% |
ZROZ | 0.03% | $1.61B | 0.15% |
XLP | -0.12% | $16.87B | 0.09% |
PDBC | -0.12% | $4.89B | 0.59% |
DBC | -0.30% | $1.36B | 0.87% |
VTEB | 0.33% | $36.03B | 0.03% |
DBO | -0.35% | $202.41M | 0.77% |
COMT | 0.36% | $684.20M | 0.48% |
AGZD | -0.50% | $134.05M | 0.23% |
GOVZ | 0.51% | $296.64M | 0.1% |
FTGC | 0.53% | $2.52B | 1.02% |
XHLF | -0.55% | $1.06B | 0.03% |
HYMB | 0.64% | $2.75B | 0.35% |
OILK | -0.66% | $67.85M | 0.69% |
TBIL | -0.67% | $5.39B | 0.15% |
XONE | 0.75% | $631.21M | 0.03% |
FMHI | -0.83% | $783.98M | 0.7% |
MMIN | -0.87% | $473.48M | 0.3% |
TBLL | -0.88% | $2.13B | 0.08% |
FTXG | 0.88% | $26.06M | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -25.82% | $416.76M | 1.43% |
VIXY | -25.05% | $195.31M | 0.85% |
TAIL | -20.31% | $87.65M | 0.59% |
JMST | -13.31% | $3.54B | 0.18% |
WEAT | -13.00% | $115.75M | 0.28% |
USDU | -11.07% | $206.96M | 0.5% |
UUP | -10.10% | $325.79M | 0.77% |
BUXX | -8.40% | $234.79M | 0.25% |
CTA | -8.40% | $978.30M | 0.76% |
DBA | -8.07% | $829.48M | 0.93% |
TPMN | -7.88% | $33.32M | 0.65% |
CCOR | -7.69% | $64.12M | 1.18% |
IYK | -7.08% | $1.53B | 0.4% |
UNG | -5.94% | $397.59M | 1.06% |
CLOI | -5.60% | $1.01B | 0.4% |
MINT | -4.93% | $13.22B | 0.35% |
IBTP | -4.18% | $111.57M | 0.07% |
IBD | -3.84% | $382.70M | 0.44% |
UGA | -3.62% | $87.23M | 0.97% |
CORN | -3.44% | $52.17M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 54.69% | $48.38M | 0.69% |
XBI | 53.65% | $4.76B | 0.35% |
GNOM | 48.10% | $47.13M | 0.5% |
PTH | 48.03% | $107.91M | 0.6% |
IBB | 47.19% | $5.61B | 0.45% |
PBE | 46.69% | $224.98M | 0.58% |
XPH | 43.49% | $158.14M | 0.35% |
IWO | 42.69% | $10.72B | 0.24% |
IWC | 42.06% | $797.08M | 0.6% |
CPSJ | 41.66% | $32.91M | 0.69% |
FBT | 41.37% | $1.08B | 0.56% |
ARKG | 40.52% | $936.86M | 0.75% |
PINK | 39.68% | $138.92M | 0.5% |
VTWO | 39.65% | $10.92B | 0.07% |
IWM | 39.49% | $62.65B | 0.19% |
QQA | 39.09% | $187.77M | 0% |
KAPR | 38.48% | $144.85M | 0.79% |
KJAN | 38.43% | $317.59M | 0.79% |
BBH | 38.19% | $358.88M | 0.35% |
EFAA | 38.07% | $100.03M | 0% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EYPT | 55.53% | $369.07M | -74.12% | 0.00% |
DNLI | 45.19% | $2.00B | -29.07% | 0.00% |
BHVN | 42.77% | $2.42B | -54.71% | 0.00% |
APGE | 42.53% | $2.25B | -36.95% | 0.00% |
ELVN | 41.46% | $973.23M | +6.83% | 0.00% |
KRYS | 41.35% | $5.21B | +1.76% | 0.00% |
LAC | 39.65% | $603.57M | -61.07% | 0.00% |
CELC | 39.53% | $354.18M | -53.20% | 0.00% |
IMVT | 39.24% | $2.79B | -47.34% | 0.00% |
PLRX | 38.51% | $86.34M | -90.23% | 0.00% |
ACLX | 38.49% | $3.69B | +6.38% | 0.00% |
YMAB | 38.47% | $217.05M | -66.71% | 0.00% |
AUTL | 38.22% | $417.82M | -71.40% | 0.00% |
VRDN | 37.79% | $1.07B | -19.62% | 0.00% |
IDYA | 37.72% | $1.43B | -61.21% | 0.00% |
BEAM | 37.53% | $1.85B | -37.74% | 0.00% |
ARWR | 37.36% | $1.74B | -52.08% | 0.00% |
DYN | 37.28% | $1.12B | -65.54% | 0.00% |
NRIX | 37.08% | $863.59M | -22.00% | 0.00% |
AMLX | 37.00% | $334.92M | +43.73% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UVE | 0.02% | $672.05M | +22.37% | 2.71% |
DNUT | -0.02% | $842.99M | -66.17% | 3.05% |
HRL | 0.04% | $16.84B | -11.83% | 3.62% |
PNW | -0.04% | $11.38B | +30.58% | 3.68% |
THG | -0.05% | $6.29B | +31.70% | 2.01% |
SIGI | 0.05% | $5.60B | -12.19% | 1.59% |
HUSA | 0.06% | $11.76M | -47.55% | 0.00% |
HRB | 0.07% | $7.58B | +21.12% | 2.55% |
WELL | 0.09% | $99.26B | +67.72% | 1.68% |
AJG | 0.09% | $87.99B | +40.23% | 0.71% |
OSCR | 0.10% | $3.35B | -4.57% | 0.00% |
IRDM | -0.10% | $2.94B | +5.38% | 2.17% |
STKL | -0.10% | $564.05M | -29.07% | 0.00% |
SRRK | 0.11% | $3.08B | +113.66% | 0.00% |
FDP | -0.12% | $1.50B | +23.65% | 3.32% |
SAN | -0.12% | $103.69B | +39.51% | 3.17% |
EW | -0.12% | $42.20B | -22.54% | 0.00% |
VSTA | -0.14% | $366.38M | +18.55% | 0.00% |
EXPD | -0.16% | $16.79B | +3.56% | 1.33% |
CAH | -0.16% | $33.50B | +25.01% | 1.47% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -25.61% | $23.50B | +25.53% | 1.05% |
MO | -14.03% | $96.57B | +35.61% | 6.83% |
AEP | -13.51% | $57.54B | +27.77% | 3.31% |
T | -13.46% | $201.99B | +59.80% | 3.85% |
SCM | -13.12% | - | - | 11.70% |
ED | -12.64% | $38.69B | +21.90% | 2.95% |
KDP | -12.47% | $47.68B | +13.32% | 2.55% |
PEP | -11.98% | $204.52B | -12.12% | 3.52% |
VZ | -11.08% | $188.34B | +4.44% | 5.84% |
CLX | -10.23% | $18.19B | +0.54% | 3.24% |
CAG | -9.49% | $12.59B | -9.22% | 5.19% |
CHD | -9.09% | $26.66B | +5.00% | 1.03% |
CPB | -8.89% | $11.75B | -8.27% | 3.73% |
KO | -8.63% | $306.97B | +19.22% | 2.66% |
PG | -8.22% | $397.45B | +8.55% | 2.32% |
ES | -8.11% | $22.99B | +7.19% | 4.61% |
KMB | -7.70% | $47.39B | +13.36% | 3.37% |
CQP | -7.52% | $32.91B | +35.41% | 5.06% |
K | -7.46% | $28.46B | +45.70% | 2.75% |
WEC | -7.40% | $34.37B | +34.01% | 3.09% |
Current Value
$7.101 Year Return
Current Value
$7.101 Year Return